Huebschman Jon C MD is categorized under Internal Medicine Doctors in Cleveland, TN and active since 2001.
Huebschman Jon C MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jon Huebschman at the company’s single location by writing to 1060 Peerless Crossing Nw # 200, Cleveland, Tennessee TN 37312 or by phoning (423) 479-4165. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Huebschman Jon C MD |
| Contact Person: | Jon Huebschman |
| Address: | 1060 Peerless Crossing Nw # 200, Cleveland, Tennessee 37312 |
| Phone Number: | (423) 479-4165 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Huebschman Jon C MD was started in 2001 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jon Huebschman for inquiries that concern Huebschman Jon C MD by calling the company number (423) 479-4165, as your correspondence is most welcome. Additionally, the physical location of the single location of Huebschman Jon C MD can be found at the coordinates 35.193128,-84.870516 as well as the street address 1060 Peerless Crossing Nw # 200 in Cleveland, Tennessee 37312.
For its online presence, you may visit Huebschman Jon C MD’s website at and engage with its social media outlets through on Twitter and on Facebook.